[ad_1]
After the European Medicines Agency (EMA) announced that AstraZeneca’s new type of coronavirus vaccine (Kovid-19) was “ safe and its benefits outweigh its risks, ” the World Health Organization (WHO) he also expressed the same opinion.
Subscribe
In the declaration of the World Health Organization (WHO); It was stated that the WHO Global Advisory Committee on Vaccine Safety met online on March 16 and 19.
In the statement; It is observed that the number of cases of new types of coronavirus (Kovid-19) worldwide has exceeded 120 million and more than 2 and a half million people died from the virus, “vaccination remains a fundamental tool for prevent further disease and death. and to help control the epidemic. “The expression was used.
In the statement that 20 million AstraZeneca vaccines have been applied so far in Europe; It was shared that in this country 27 million vaccination doses were made from the Covishield vaccine (AstraZeneca-Oxford vaccine produced by the Indian Serum Institute) produced in India.
In the statement; In research by the WHO Global Advisory Committee on Vaccine Safety, it was concluded that ‘the benefits of AstraZeneca’s Kovid-19 vaccine (including Covishield) outweigh the risks and has enormous potential to prevent infections and reduce deaths in all the world.
“This vaccine is safe and effective”
The European Medicines Agency (EMA) also announced the result of its scientific evaluation after some European countries, including Germany, France, Italy and Spain, suspended the use of the AstraZeneca vaccine on suspicion of causing side effects such as blood clotting. blood. Emer Cooke, director of the EMA, said: “This vaccine is safe and effective. The benefits of the vaccine to protect people from Kovid-19 disease outweigh its possible risks.”
